| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000030490 |
| Receipt No. | R000034773 |
| Official scientific title of the study | Efficacy of preoperative amino acids administration on postoperative physical function and complications for elderly patients undergoing open heart surgery: a single center randomized controlled trial |
| Date of disclosure of the study information | 2018/03/01 |
| Last modified on | 2018/08/30 (Ver. 12) |
| Basic information | ||
| Official scientific title of the study | Efficacy of preoperative amino acids administration on postoperative physical function and complications for elderly patients undergoing open heart surgery: a single center randomized controlled trial | |
| Title of the study (Brief title) | Efficay of preoperative amino acids administaration on post cardiac surgery course | |
| Region |
|
|
| Condition | |||||
| Condition | patients undergoing open-heart surgery | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | To clarify the effect of short-term amino acid administartion on post operative physical function and complications. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Difference for change in 6-minute walk test distance between pre- and post-operation. |
| Key secondary outcomes | 1. Difference for incidence of postoperative complications.
2. Difference for changes in nutritional status. 3. Difference for change in physical function (grip strength, knee extensor muscle strength, body composition, short physical performance battery score, and physical activity estimates). 4. Difference in psychological, and health status. 5. Difference for changes in inflammatory status. 6. Difference for hospital mortality 7. Difference for hospital length of stay 8. Difference for ICU length of stay |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Oral administraion of amino acid (abund) for 14-28 days | |
| Interventions/Control_2 | No intervention
|
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients undergoing open-heart surgery in Kobe University Hospital.
1. Patietns with age greater than or equal to 65 years 2. Patients who agreed to study participants |
|||
| Key exclusion criteria | 1. patients with BNP more than 500pg/ml.
2. patients with eGFR<30ml/min/1.73m2. 3. patients with T-Bil>2.0mg/dL 4. patients with congenital branched chain amino acid metabolism disorders 5. Patients whose consent was not obtained 6.Participation in any clinical research study evaluating another investigational drug or therapy within 4 months prior to randomization 7. presence of other conditions, which make the patient unsuitable for the study according to the judgment of the principal investigatoror or coinvestigator. 8. Patients who can not perform 6 minutes walking test 9. Patients who take amino acids supplements prior to randomization |
|||
| Target sample size | 200 | |||
| Research contact person | |
| Name of lead principal investigator | Seimi Kobayashi |
| Organization | Kobe university hospital |
| Division name | Cardiovascular medicine |
| Address | 7-5-2 Kusunoki-cho, Chuo-ku, Kobe 6500017, Japan |
| TEL | 078-382-5846 |
| seimik@med.kobe-u.ac.jp | |
| Public contact | |
| Name of contact person | Seimi Kobayashi |
| Organization | Kobe university hospital |
| Division name | Cardiovascular medicine |
| Address | 7-5-2 Kusunoki-cho, Chuo-ku, Kobe 6500017, Japan |
| TEL | 078-382-5846 |
| Homepage URL | |
| seimik@med.kobe-u.ac.jp | |
| Sponsor | |
| Institute | Kobe university |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kobe university |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 神戸大学医学部附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034773 |